Robert Torray
Torray Fund
Torray Fund UnitedHealth Group Incorporated stake
total: 71
Torray Fund UNH trades
- Total transactions:
- 11
- New positions:
- 1
- Sold out:
- 1
- Added:
- 3
- Reduced:
- 6
- Held since:
- 2020 Q1
- Held for:
- 24 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Torray Fund doesn't hold any UnitedHealth Group Incorporated (UNH) shares. To date, the estimated cost basis is nearly $271.94 for "buy" trades and estimated average "sell" price is $388.55. Torray Fund first purchased UNH in 2020 Q1, initially acquiring 43,050 shares. Since the initial investment in UnitedHealth Group Incorporated (UNH), Torray Fund has made 10 more transactions.
When did Torray Fund sell UnitedHealth Group Incorporated (UNH)?
Torray Fund sold off the entire UnitedHealth Group Incorporated (UNH) position in 2026 Q1.
When did Torray Fund buy UnitedHealth Group Incorporated (UNH)?
Torray Fund first invested in UnitedHealth Group Incorporated (UNH) in 2020 Q1 at the reported quarter-end price of $249.38 per share.
What's the cost basis of Torray Fund's UNH stake?
The estimated cost basis for UnitedHealth Group Incorporated (UNH) stake is around $271.94 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $271.94
- Weighted AVG sell price:
- $388.55
Torray Fund's historical trades in UnitedHealth Group Incorporated
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.00%
|
0
|
$329.77
|
|
-100% (-45,000)
|
-4.15%
|
|
2025 Q4
|
4.15%
|
45,000
|
$329.77
|
$14,839,650
|
+16.37% (+6,330)
|
+0.58%
|
|
2025 Q3
|
3.32%
|
38,670
|
$309.87
|
$11,982,673
|
+27.00% (+8,220)
|
+0.71%
|
|
2025 Q2
|
2.77%
|
30,450
|
$301.91
|
$9,193,160
|
+47.35% (+9,785)
|
+0.89%
|
|
2024 Q4
|
3.50%
|
20,665
|
$610.20
|
$12,609,783
|
-20.85% (-5,443)
|
-0.94%
|
|
2022 Q2
|
4.42%
|
26,108
|
$513.63
|
$13,409,852
|
-13.63% (-4,121)
|
-0.59%
|
|
2022 Q1
|
4.32%
|
30,229
|
$509.97
|
$15,415,883
|
-11.27% (-3,838)
|
-0.52%
|
|
2021 Q4
|
4.53%
|
34,067
|
$502.14
|
$17,106,403
|
-9.73% (-3,672)
|
-0.5%
|
|
2021 Q3
|
3.99%
|
37,739
|
$390.74
|
$14,746,137
|
-5.91% (-2,371)
|
-0.23%
|
|
2021 Q2
|
4.03%
|
40,110
|
$400.44
|
$16,061,648
|
-6.83% (-2,940)
|
-0.3%
|
|
2020 Q1
|
3.63%
|
$249.38
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.